The Worldwide Contract Research Organizations (CRO) Industry is Expected to Grow to $64.4 Billion by 2027
January 08, 2021 05:23 ET
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Contract Research Organizations (CRO) Market by Services (Clinical Research [Phase II, Phase III], Pre-Clinical [Pharmacokinetics, Toxicology],...
Global Therapeutic Drug Monitoring (TDM) Technologies, Markets & Companies Report 2020: Description of 35 Companies Involved with Their Collaborations in this Area
November 03, 2020 03:33 ET
|
Research and Markets
Dublin, Nov. 03, 2020 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's...
Therapeutic Drug Monitoring Market by Product, Technology, Class of Drugs, End-user - Global Forecast to 2025
September 22, 2020 07:13 ET
|
Research and Markets
Dublin, Sept. 22, 2020 (GLOBE NEWSWIRE) -- The "Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of...
aTyr Pharma Announces Positive Phase 1 Data for ATYR1923 Therapeutic Candidate
June 26, 2018 08:00 ET
|
aTyr Pharma, Inc.
ATYR1923 Well-Tolerated at all Doses Tested, with No Significant Adverse Events Pharmacokinetic Profile Supports Potential Once-Monthly Dosing SAN DIEGO, June 26, 2018 (GLOBE NEWSWIRE) -- aTyr...
AXIM® Biotech Receives Positive PK Data Results for CanChew Plus® CBD Gum
January 04, 2017 09:00 ET
|
AXIM Biotechnologies, Inc
NEW YORK, Jan. 04, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, received positive pharmacokinetic (PK)...